The global retail industry experienced a 74% drop in company filings mentions of COVID-19 in Q2 2023 compared with the previous quarter, with the highest share accounted for by CVS Health with 19% year-on-year decrease, according to GlobalData’s analysis of over 463 retail company filings. GlobalData’s COVID-19 Cross-Sector Impact – Thematic Research report helps understand how the effect of COVID-19 on Retail sector compares with 17 other key sectors, in terms of equity indices, M&A volumes, jobs index, and filings. Buy the report here.
Notably, COVID-19 was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of electric vehicles and cyber insurance, according to GlobalData.
Of the top leading companies in the retail industry, CVS Health had the greatest increase in references for COVID-19 in Q2 2023, compared with the previous quarter. GlobalData identified 47 COVID-19-related sentences in the company's filings - 5% of all sentences - and a decrease of 19% in Q2 2023 compared with Q2 2022. JD’s mentions of COVID-19 dropped by 47% to 37 and Walgreens Boots Alliance’s by 36% to 34 and Next’s by 54% to 24 and Burberry Group’s by 84% to 23.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for COVID-19 in Q2 2023 was 158.
To further understand GlobalData's analysis on COVID-19 Cross-Sector Impact - Thematic Research, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.